IBIO vs QRVO · rev $100.0K vs P/E 27, rev $3.68B
iBio, Inc. Common Stock (IBIO) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
IBIO currently screens at market cap $13.4M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the IBIO and QRVO stock pages for the full models.
Not investment advice.